In a mouse fibroblast line, IL-17A increased the expression of TGF-β, connective tissue growth factor (CTGF) and collagen but increased skin and lung inflammation and fibrosis in a mouse bleomycin (BLM) model of SSc [64, 65]. Here, IL17A is linked to systemic sclerosis.